These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 16481149)
1. Prevalence of the metabolic syndrome in patients with schizophrenia treated with antipsychotic medication. De Hert MA; van Winkel R; Van Eyck D; Hanssens L; Wampers M; Scheen A; Peuskens J Schizophr Res; 2006 Mar; 83(1):87-93. PubMed ID: 16481149 [TBL] [Abstract][Full Text] [Related]
2. Prevalence of diabetes and the metabolic syndrome in a sample of patients with bipolar disorder. van Winkel R; De Hert M; Van Eyck D; Hanssens L; Wampers M; Scheen A; Peuskens J Bipolar Disord; 2008 Mar; 10(2):342-8. PubMed ID: 18271914 [TBL] [Abstract][Full Text] [Related]
3. Prevalence of metabolic syndrome among an Iranian cohort of inpatients with schizophrenia. Rezaei O; Khodaie-Ardakani MR; Mandegar MH; Dogmehchi E; Goodarzynejad H Int J Psychiatry Med; 2009; 39(4):451-62. PubMed ID: 20391865 [TBL] [Abstract][Full Text] [Related]
4. Metabolic syndrome and antipsychotic monotherapy treatment among schizophrenia patients in Malaysia. Said MA; Hatim A; Habil MH; Zafidah W; Haslina MY; Badiah Y; Ramli MA; Ananjit S; Sapini Y; Shah M; Mahmud B; Bulgiba A; Hairi NN Prev Med; 2013; 57 Suppl():S50-3. PubMed ID: 23337566 [TBL] [Abstract][Full Text] [Related]
5. Metabolic syndrome and cardiovascular risk among patients with schizophrenia receiving antipsychotics in Malaysia. Said MA; Sulaiman AH; Habil MH; Das S; Bakar AK; Yusoff RM; Loo TH; Bakar SA Singapore Med J; 2012 Dec; 53(12):801-7. PubMed ID: 23268153 [TBL] [Abstract][Full Text] [Related]
6. Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III. McEvoy JP; Meyer JM; Goff DC; Nasrallah HA; Davis SM; Sullivan L; Meltzer HY; Hsiao J; Scott Stroup T; Lieberman JA Schizophr Res; 2005 Dec; 80(1):19-32. PubMed ID: 16137860 [TBL] [Abstract][Full Text] [Related]
7. Metabolic syndrome among psychiatric inpatients with schizophrenia in Indonesia. Marthoenis M; Aichberger MC; Puteh I; Syahrial S; Schouler-Ocak M Asian J Psychiatr; 2015 Jun; 15():10-4. PubMed ID: 25910596 [TBL] [Abstract][Full Text] [Related]
8. [Prevalence of metabolic syndrome in Spanish patients with schizophrenia and overweight. The CRESSOB Study]. Gutiérrez-Rojas L; Azanza JR; Bernardo M; Rojo L; Mesa F; Martínez-Ortega JM Actas Esp Psiquiatr; 2014; 42(1):9-17. PubMed ID: 24504989 [TBL] [Abstract][Full Text] [Related]
9. Prevalence of vascular disease in metabolic syndrome using three proposed definitions. Athyros VG; Ganotakis ES; Elisaf MS; Liberopoulos EN; Goudevenos IA; Karagiannis A; Int J Cardiol; 2007 Apr; 117(2):204-10. PubMed ID: 16854482 [TBL] [Abstract][Full Text] [Related]
10. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness]. Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM; Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369 [TBL] [Abstract][Full Text] [Related]
11. Prevalence of the metabolic syndrome in schizophrenic patients receiving second-generation antipsychotic agents--a cross-sectional study. Kagal UA; Torgal SS; Patil NM; Malleshappa A J Pharm Pract; 2012 Jun; 25(3):368-73. PubMed ID: 22551560 [TBL] [Abstract][Full Text] [Related]
12. Prevalence of metabolic syndrome according to Adult Treatment Panel III and International Diabetes Federation criteria: a population-based study. Bener A; Zirie M; Musallam M; Khader YS; Al-Hamaq AO Metab Syndr Relat Disord; 2009 Jun; 7(3):221-9. PubMed ID: 19320557 [TBL] [Abstract][Full Text] [Related]
13. A two fold risk of metabolic syndrome in a sample of patients with schizophrenia: do consanguinity and family history increase risk? Bener A; Al-Hamaq AO; Dafeeah EE Diabetes Metab Syndr; 2014; 8(1):24-9. PubMed ID: 24661754 [TBL] [Abstract][Full Text] [Related]
14. Metabolic syndrome in first episode schizophrenia - a randomized double-blind controlled, short-term prospective study. Saddichha S; Manjunatha N; Ameen S; Akhtar S Schizophr Res; 2008 Apr; 101(1-3):266-72. PubMed ID: 18262771 [TBL] [Abstract][Full Text] [Related]
15. Atypical antipsychotic drugs, schizophrenia, and metabolic syndrome in non-Euro-American societies. Bou Khalil R Clin Neuropharmacol; 2012; 35(3):141-7. PubMed ID: 22592510 [TBL] [Abstract][Full Text] [Related]
16. Frequency of metabolic syndrome among hemodialysis patients according to NCEP-ATP III and IDF definitions. Ucar E; Huzmeli C; Guven O; Savas N; Gullu M; Asilyoruk S; Kuvandik C; Temizkan A; Kuvandik G Ren Fail; 2009; 31(3):221-8. PubMed ID: 19288328 [TBL] [Abstract][Full Text] [Related]
17. The Clinical Antipsychotic Trials Of Intervention Effectiveness (CATIE) Schizophrenia Trial: clinical comparison of subgroups with and without the metabolic syndrome. Meyer JM; Nasrallah HA; McEvoy JP; Goff DC; Davis SM; Chakos M; Patel JK; Keefe RS; Stroup TS; Lieberman JA Schizophr Res; 2005 Dec; 80(1):9-18. PubMed ID: 16125372 [TBL] [Abstract][Full Text] [Related]
18. Prevalence and predictors of metabolic syndrome among patients attending an outpatient clozapine clinic in Australia. Brunero S; Lamont S; Fairbrother G Arch Psychiatr Nurs; 2009 Jun; 23(3):261-8. PubMed ID: 19446781 [TBL] [Abstract][Full Text] [Related]
19. Prevalence of the metabolic syndrome in Danish psychiatric outpatients treated with antipsychotics. Krane-Gartiser K; Breum L; Glümrr C; Linneberg A; Madsen M; Køster A; Jepsen PW; Fink-Jensen A Nord J Psychiatry; 2011 Oct; 65(5):345-52. PubMed ID: 21428861 [TBL] [Abstract][Full Text] [Related]
20. Metabolic complications of schizophrenia and antipsychotic medications--an updated review. Yogaratnam J; Biswas N; Vadivel R; Jacob R East Asian Arch Psychiatry; 2013 Mar; 23(1):21-8. PubMed ID: 23535629 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]